The Navigators regularly receive questions covering a wide range of topics about conducting research studies at Johns Hopkins. It is not uncommon for multiple investigators…
Sickle cells. Credit: adobe iStock A national, multicenter clinical trial (BMT CTN 1507) of low-dose haploidentical (half-matched) bone marrow transplant to treat severe sickle cell…
This article discusses the work of Barbara Slusher, PhD, MAS, director of Johns Hopkins Drug Discovery, and co-leader of the ICTR Drug, Biologics, Vaccines and Devices Translational Research Community.…
Article courtesy of the NIH A monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume without…
Using a “liquid biopsy” to study genetic material from tumors shed into the bloodstream together with immune cells could help clinicians predict which patients with…
Comparing PET scans of more than 90 adults with and without mild cognitive impairment (MCI), Johns Hopkins Medicine researchers say relatively lower levels of the…
A study of more than 50 babies through age 2 in Africa, Asia, North America and South America has added substantially to evidence that giving…
Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies…
Program Fact Sheet Apply The Translational Science Interagency Fellowship (TSIF) is a postdoctoral fellowship opportunity developed by the National Center for Advancing Translational Sciences (NCATS)…
A recent study from researchers at the Johns Hopkins University School of Medicine — published Oct. 26 in Cell Chemical Biology — indicates that newly designed AMPK-targeting…